KOR

e-Article

EBSCO Discovery Service
Publication date
-
(ex : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'e-Article' searched 52results | List 1~20
Academic Journal
Chabrun F; Angers University Hospital.; Schwartz D; Dana-Farber Cancer Institute.; Gentile S; Dana-Farber Cancer Institute.; Mai E; Heidelberg University Hospital.; Gupta T; Dana Farber Cancer Institute.; Perry J; Dana-Farber Cancer Institute.; Santos DCD; Dana-Farber Cancer Institute.; Hielscher T; German Cancer Research Center (DKFZ).; Werly A; Heidelberg University Hospital and Medical Faculty Heidelberg.; Schmidt S; Heidelberg University Hospital and Medical Faculty Heidelberg.; Theodorakakou F; National and Kapodistrian University of Athens.; Fotiou D; National and Kapodistrian University of Athens.; Liacos C; National and Kapodistrian University of Athens.; Kanellias N; National and Kapodistrian University of Athens.; Gisbert N; Cancer Center Clinica Universidad de Navarra.; Martin-Sanchez E; Cancer Center Clinica Universidad de Navarra.; Termini R; Cancer Center Clinica Universidad de Navarra.; Waldschmidt J; University Hospital Wuerzburg.; Chavda S; University College London.; Ainley L; University College London.; Vià MCD; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.; de Magistris C; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.; Pettine L; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.; Timonian M; Dana-Farber Cancer Institute, Harvard Medical School, Broad Institute of MIT & Harvard.; Alberge JB; Dana-Farber Cancer Institute.; Patel V; Dana-Farber Cancer Institute.; Costello P; Dana-Farber Cancer Institute.; Tobia C; Dana-Farber Cancer Institute.; Phan S; Dana-Farber Cancer Institute.; Lamb J; Dana-Farber Cancer Institute.; Silverio MT; Dana-Farber Cancer Institute.; Davis M; Dana-Farber Cancer Institute.; O'Donnell E; Dana-Farber Cancer Institute.; Marinac C; Dana-Farber Cancer Institute.; Nadeem O; Dana-Farber Cancer Institute.; Bolli N; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.; Yong K; University College London.; Kortüm M; University Hospital Würzburg.; Einsele H; University Hospital Würzburg.; Manteca MVM; Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBASL), Centro de Investigación del Cáncer (IBMCC-USAL,CSIC).; Kumar S; Mayo clinic.; Miguel JS; University of Navarra.; Paiva B; Cancer Center Clinica Universidad de Navarra.; Kastritis E; National and Kapodistrian University of Athens School of Medicine.; Dimopoulos M; School of Medicine, National and Kapodistrian University of Athens.; Raab M; Heidelberg University Hospital, German Cancer Research Center (DKFZ).; Trippa L; Dana-Farber Cancer Institute.; Ghobrial I; Dana-Farber Cancer Institute.
Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet ISSN: 2693-5015 (Electronic) Linking ISSN: 26935015 NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE
Academic Journal
Diamond B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.; Chahar D; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, FL, USA.; Jain MD; Lymphoma Service, Moffitt Cancer Center, Tampa, FL, USA.; Poos AM; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Durante M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.; Ziccheddu B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.; Kaddoura M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.; Papadimitriou M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.; Maclachlan K; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Jelinek T; Department of Hemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Czech Republic.; Davies F; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA.; Figura NB; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA.; Morgan G; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA.; Mai E; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Weisel KC; Department of Oncology, Hematology and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Fenk R; Department of Hematology, Oncology and Clinical Immunology, University-Hospital Duesseldorf, Duesseldorf, Germany.; Raab MS; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Usmani S; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Landgren O; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.; Locke FL; Lymphoma Service, Moffitt Cancer Center, Tampa, FL, USA.; Goldschmidt H; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Schatz JH; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, FL, USA.; Weinhold N; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Maura F; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Academic Journal
Best Practice Onkologie. Oct2014, Vol. 9 Issue 5, p6-15. 10p.
Refining the search results
Facets
[AR] Mai, Elias
Publication year
-
Database provider
Title
Publisher
자료유형(Source Type)
Subject
Language